Renal Denervation in Heart Failure Patients With Preserved Ejection Fraction (RESPECT-HF)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 144 participants.
Also called NCT02041130
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 144 participants
- Sponsor
- Registry
-
NCT02041130
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Australia, New Zealand, Singapore
- Registry status
- Unknown status
Technical summary
Registry record NCT02041130. Randomized; no masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Renal Denervation in Heart Failure Patients With Preserved Ejection Fraction (RESPECT-HF)
- Acronym
- RESPECT-HF
- Condition
- Heart Failure
- Intervention (Device)
- Renal Denervation
- Lead sponsor
- National University Hospital, Singapore
- Collaborator
- University of Otago
- Collaborator
- Wellington Hospital
- Collaborator
- University of Auckland, New Zealand
- Collaborator
- Monash University
- Collaborator
- Tan Tock Seng Hospital
- Collaborator
- Changi General Hospital
- Collaborator
- Singapore Clinical Research Institute
Record details
- Record id
cardio:ct-nct02041130- Content hash
5f0eb453a7663a9915c65ea0d5b9e1cc17b297a93a1e01c022343614b1cc1a0a